A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
Clinical trial NCT02990325 · COMPLETED
Trial details
- NCT number
- NCT02990325
- Sponsor
- Abivax S.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2018-12-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.